Skip to main content
Ipsen Home Page
Press shift tab to select search category

Loading...
  • Press Releases
  • Investors
  • emc易倍官网入口 Partnering
  • Careers arrow down
      < Back
    • Careers
    • emc易倍官网入口Careers
    • Working at Ipsen
  • Press shift tab to select search category

    Loading...
  •         EN  arrow_down
    • English EN
    • Fran?ais FR
  •  Canada
    <
    • Global EN FR
    • Annual Report EN FR
    • Americas
    • Asia Pacific
    • Europe
    • Middle East & Africa
    • emc易倍官网入口 Brazil
    • Canada
    • United States
    • Mexico
    • Australia
    • China
    • emc易倍官网入口 Singapore
    • emc易倍官网入口 South Korea
    • Japan
    • emc易倍官网入口 Belgium
    • Ukraine
    • UK
    • Germany
    • France
    • Nordics
    • Greece
    • Italy
    • Netherlands
    • Spain
    • Poland
    • Russia
    • Czech Republic
    • Romania
    • Hungary
    • emc易倍官网入口 Slovakia
    • Switzerland
    • Austria
    • UAE & Gulf
    • Saudi Arabia
  • Home
  • Company
      < Back
    • Company
    • Who We Are
    • Leadership
    • Our History
  • Science
      < Back
    • Science
    • emc易倍官网入口Areas of Focus
    • Products
    • emc易倍官网入口Clinical Trials
    • R&D
    • Grant Requests
    • Investigator Sponsored Studies
  • Sustainability
      < Back
    • Sustainability
    • Sustainability
    • Environment
    • People
    • emc易倍官网入口Governance
    • Charitable Contributions
  • Patients
  1. Home
  2. emc易倍官网入口Company – Leadership

emc易倍官网入口

emc易倍官网入口

Ed Dybka

emc易倍官网入口

General Manager

Ipsen Canada

Corinne Barr

emc易倍官网入口

Senior Director

Oncology Business Unit

Brad Carter

emc易倍官网入口

Senior Director

Finance and Supply Chain

Phyllis Ioannou

emc易倍官网入口

Senior Director

Value & Access and Patient Support Programs

Bryan Laskey

emc易倍官网入口

Senior Director

Neuroscience & Rare Disease Business Unit

Vita Peri

emc易倍官网入口

Senior Director

Business Operations & Strategy

Walid Shammas

emc易倍官网入口

Senior Director

Medical and Regulatory Affairs

Pauline Watrice

emc易倍官网入口

Human Resources, Canada

IPN price

€156.90

 €-3.70 (-2.30%)

  • Investors
  • Partnering
  • Careers
  • Who We Are
  • Sustainability
  • Contact us

Ipsen logo
Linkedin Instagram Facebook Youtube
  • Terms of Use
  • emc易倍官网入口Cookie Policy
  • emc易倍官网入口Privacy Policy
  • emc易倍官网入口Accessibility

? Ipsen Pharma. All rights reserved - 2026

You are now leaving the Ipsen Canada website. To continue, please click Continue.

emc易倍官网入口 Continue

2026-07-16 16:43:03